Table 3.
Uniformity of content of LG MAS and LGL MAS.
| Drug (%) | ||||
|---|---|---|---|---|
| LG MAS | LGL MAS | |||
| Assay | M | AS | M | AS |
| 1 | 94.07 | 54.23 | 98.53 | 87.19 |
| 2 | 98.01 | 45.12 | 97.27 | 91.27 |
| 3 | 101.28 | 42.73 | 98.83 | 90.01 |
| 4 | 95.33 | 55.04 | 97.97 | 85.55 |
| 5 | 95.58 | 51.09 | 93.74 | 90.88 |
| 6 | 94.67 | 55.37 | 98.35 | 86.85 |
| 7 | 95.99 | 51.56 | 100.43 | 86.91 |
| 8 | 92.53 | 51.09 | 96.09 | 86.76 |
| 9 | 97.19 | 45.31 | 92.70 | 90.25 |
| 10 | 101.25 | 47.24 | 100.90 | 85.74 |
| Mean | 96.59 | 49.88 | 97.48 | 88.14 |
| SD | 2.90 | 4.51 | 2.65 | 2.20 |
| CV | 3.00 | 9.04 | 2.72 | 2.50 |